• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:陈星妍,崔韶晖,杜桑,张树彪.细胞膜修饰纳米粒药物递送系统的研究进展[J].中国现代应用药学,2022,39(22):3024-3029.
CHEN Xingyan,CUI Shaohui,DU Sang,ZHANG Shubiao.Research Progress of Cell Membrane Modified Nanoparticle Drug Delivery System[J].Chin J Mod Appl Pharm(中国现代应用药学),2022,39(22):3024-3029.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1011次   下载 1005 本文二维码信息
码上扫一扫!
分享到: 微信 更多
细胞膜修饰纳米粒药物递送系统的研究进展
陈星妍, 崔韶晖, 杜桑, 张树彪
大连民族大学生物技术与资源利用教育部重点实验室, 辽宁 大连 116601
摘要:
纳米粒是药物递送系统研究的热点之一,但仍存在体内循环时间短,易被网状内皮系统识别和清除等缺点,限制了其临床应用。近年来,天然细胞膜成分和纳米技术的结合为解决这些问题提供了新的方案。一种由纳米粒核和细胞膜壳组成的新型仿生系统极大地改善了纳米粒的性能。用细胞膜修饰的纳米粒具有独特的功能,如延长血液循环时间,提高主动靶向和增强细胞内化等功能。本文综述了细胞膜修饰纳米粒药物递送系统的最新进展及其在癌症治疗方面的应用前景。
关键词:  细胞膜|纳米粒|仿生纳米粒|药物递送系统|癌症治疗
DOI:10.13748/j.cnki.issn1007-7693.2022.22.019
分类号:R965.2
基金项目:国家自然科学基金项目(21776044)
Research Progress of Cell Membrane Modified Nanoparticle Drug Delivery System
CHEN Xingyan, CUI Shaohui, DU Sang, ZHANG Shubiao
Key Laboratory of Biotechnology and Bioresources Utilization, Ministry of Education, Dalian Minzu University, Dalian 116600, China
Abstract:
Nanoparticles that are research hotspots in drug delivery systems, still have some disadvantages such as short circulation time in vivo, ease of recognition and clearance by reticuloendothelial system, which limit clinical applications. In recent years, the combinations of natural cell membrane components and nanotechnology have provided new solutions to these problems. A novel bionic system composed of nanoparticle core and cell membrane shell greatly can improve the performance of nanoparticles. Nanoparticles coated by cell membranes are endowed with unique functions such as prolonged blood circulation, active targeting capability and enhanced internalization. This review focus on the newest development of cell membrane- modified nanoparticles drug delivery systems and introduce their application prospects in cancer therapy.
Key words:  cell membrane|nanoparticles|biomimetic nanoparticles|drug delivery system|tumor therapy
扫一扫关注本刊微信